{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HMGCoA reductase inhibitors", "cardiovascular diseases", "sirtuins", "statins"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35629426", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "20"}], "Language": ["eng"], "ELocationID": ["760", "10.3390/life12050760"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "12", "Issue": "5", "PubDate": {"Year": "2022", "Month": "May", "Day": "20"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases.", "Abstract": {"AbstractText": ["Adverse cardiovascular disease (CVD) outcomes, such as sudden cardiac death, acute myocardial infarction, and stroke, are often catastrophic. Statins are frequently used to attenuate the risk of CVD-associated morbidity and mortality through their impact on lipids and they may also have anti-inflammatory and other plaque-stabilization effects via different signaling pathways. Different statins, including atorvastatin, rosuvastatin, pravastatin, pitavastatin, and simvastatin, are administered to manage circulatory lipid levels. In addition, statins are potent inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase via modulating sirtuins (SIRTs). During the last two decades, SIRTs have been investigated in mammals and categorized as a family of nicotinamide adenine dinucleotide (NAD)-dependent histone deacetylases (HDACs) with significant oxidative stress regulatory function in cells-a key factor in extending cell lifespan. Recent work has demonstrated that statins upregulate SIRT1 and SIRT2 and downregulate SIRT6 in both in vitro and in vivo experiments and clinical trials. As statins show modulatory properties, especially in CVDs, future investigations are needed to delineate the role of SIRT family members in disease and to expand knowledge about the effects of statins on SIRTs. Here, we review what is currently known about the impact of statins on SIRTs and how these changes correlate with disease, particularly CVDs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Khayatan", "ForeName": "Danial", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Razavi", "ForeName": "Seyed Mehrad", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Arab", "ForeName": "Zahra Najafi", "Initials": "ZN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}], "LastName": "Khanahmadi", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": ["0000-0002-5762-3917"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Department, Royal College of Surgeons in Ireland, Adliya P.O. Box 15503, Bahrain."}], "LastName": "Butler", "ForeName": "Alexandra E", "Initials": "AE"}, {"Identifier": ["0000-0003-0823-8729"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy."}, {"Identifier": [], "Affiliation": "IRCCS Ospedale Policlinico San Martino Genova-Italian Cardiovascular Network, 16132 Genoa, Italy."}], "LastName": "Montecucco", "ForeName": "Fabrizio", "Initials": "F"}, {"Identifier": ["0000-0002-3781-6340"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cellular and Molecular Pathology of Cardiovascular System, Avtsyn Research Institute of Human Morphology of FSBI \"Petrovsky National Research Center of Surgery\", 3 Tsyurupy Str., 117418 Moscow, Russia."}], "LastName": "Markina", "ForeName": "Yuliya V", "Initials": "YV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "GrantList": [{"GrantID": "Grant # 22-25-00190", "Agency": "Russian Science Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Costantino S., Paneni F., Cosentino F. Ageing, metabolism and cardiovascular disease. J. Physiol. 2016;594:2061\u20132073. doi: 10.1113/JP270538.", "ArticleIdList": ["10.1113/JP270538", "PMC4933114", "26391109"]}, {"Citation": "Oesterle A., Laufs U., Liao J.K. Pleiotropic Effects of Statins on the Cardiovascular System. Circ. Res. 2017;120:229\u2013243. doi: 10.1161/CIRCRESAHA.116.308537.", "ArticleIdList": ["10.1161/CIRCRESAHA.116.308537", "PMC5467317", "28057795"]}, {"Citation": "Kilic U., Gok O., Elibol-Can B., Uysal O., Bacaksiz A. Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: The role of sirtuin 1 gene variants in human coronary atherosclerosis. Clin. Exp. Pharmacol. Physiol. 2015;42:321\u2013330. doi: 10.1111/1440-1681.12362.", "ArticleIdList": ["10.1111/1440-1681.12362", "25582759"]}, {"Citation": "Bahrami A., Bo S., Jamialahmadi T., Sahebkar A. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms. Ageing Res. Rev. 2020;58:101024. doi: 10.1016/j.arr.2020.101024.", "ArticleIdList": ["10.1016/j.arr.2020.101024", "32006687"]}, {"Citation": "Gorabi A.M., Kiaie N., Pirro M., Bianconi V., Jamialahmadi T., Sahebkar A. Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications. Heart Fail. Rev. 2021;26:1259\u20131272. doi: 10.1007/s10741-020-09929-9.", "ArticleIdList": ["10.1007/s10741-020-09929-9", "32008148"]}, {"Citation": "Reiner \u017d., Hatamipour M., Banach M., Pirro M., Al-Rasadi K., Jamialahmadi T., Radenkovic D., Montecucco F., Sahebkar A. Statins and the COVID-19 main protease: In silico evidence on direct interaction. Arch. Med. Sci. 2020;16:490\u2013496. doi: 10.5114/aoms.2020.94655.", "ArticleIdList": ["10.5114/aoms.2020.94655", "PMC7212226", "32399094"]}, {"Citation": "Sahebkar A., Serban C., Mikhailidis D.P., Undas A., Lip G.Y., Muntner P., Bittner V., Ray K.K., Watts G.F., Hovingh G.K., et al. Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb. Haemost. 2015;114:546\u2013557. doi: 10.1160/th14-11-0937.", "ArticleIdList": ["10.1160/th14-11-0937", "26017749"]}, {"Citation": "Sohrevardi S.M., Nasab F.S., Mirjalili M.R., Bagherniya M., Tafti A.D., Jarrahzadeh M.H., Azarpazhooh M.R., Saeidmanesh M., Banach M., Jamialahmadi T., et al. Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Arch. Med. Sci. 2021;17:1423\u20131428. doi: 10.5114/aoms.2019.89330.", "ArticleIdList": ["10.5114/aoms.2019.89330", "PMC8425261", "34522273"]}, {"Citation": "Vahedian-Azimi A., Mohammadi S.M., Heidari Beni F., Banach M., Guest P.C., Jamialahmadi T., Sahebkar A. Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: A systematic review and meta-analysis. Arch. Med. Sci. 2021;17:579\u2013595. doi: 10.5114/aoms/132950.", "ArticleIdList": ["10.5114/aoms/132950", "PMC8130467", "34025827"]}, {"Citation": "Sahebkar A., Kotani K., Serban C., Ursoniu S., Mikhailidis D.P., Jones S.R., Ray K.K., Blaha M.J., Rysz J., Toth P.P., et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. Atherosclerosis. 2015;241:433\u2013442. doi: 10.1016/j.atherosclerosis.2015.05.022.", "ArticleIdList": ["10.1016/j.atherosclerosis.2015.05.022", "26074317"]}, {"Citation": "Chamani S., Liberale L., Mobasheri L., Montecucco F., Al-Rasadi K., Jamialahmadi T., Sahebkar A. The role of statins in the differentiation and function of bone cells. Eur. J. Clin. Investig. 2021;51:e13534. doi: 10.1111/eci.13534.", "ArticleIdList": ["10.1111/eci.13534", "33656763"]}, {"Citation": "Dehnavi S., Kiani A., Sadeghi M., Biregani A.F., Banach M., Atkin S.L., Jamialahmadi T., Sahebkar A. Targeting AMPK by Statins: A Potential Therapeutic Approach. Drugs. 2021;81:923\u2013933. doi: 10.1007/s40265-021-01510-4.", "ArticleIdList": ["10.1007/s40265-021-01510-4", "PMC8144155", "33939118"]}, {"Citation": "Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:III39\u2013III43. doi: 10.1161/01.CIR.0000131517.20177.5a.", "ArticleIdList": ["10.1161/01.CIR.0000131517.20177.5a", "15198965"]}, {"Citation": "Oesterle A., Liao J.K. The Pleiotropic Effects of Statins\u2014From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr. Vasc. Pharmacol. 2019;17:222\u2013232. doi: 10.2174/1570161116666180817155058.", "ArticleIdList": ["10.2174/1570161116666180817155058", "PMC6378117", "30124154"]}, {"Citation": "Wang S., Xie X., Lei T., Zhang K., Lai B., Zhang Z., Guan Y., Mao G., Xiao L., Wang N. Statins Attenuate Activation of the NLRP3 Inflammasome by Oxidized LDL or TNF\u03b1 in Vascular Endothelial Cells through a PXR-Dependent Mechanism. Mol. Pharmacol. 2017;92:256\u2013264. doi: 10.1124/mol.116.108100.", "ArticleIdList": ["10.1124/mol.116.108100", "28546421"]}, {"Citation": "Chru\u015bciel P., Sahebkar A., Rembek-Wieliczko M., Serban M.C., Ursoniu S., Mikhailidis D.P., Jones S.R., Mosteoru S., Blaha M.J., Martin S.S., et al. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208. doi: 10.1016/j.atherosclerosis.2016.07.897.", "ArticleIdList": ["10.1016/j.atherosclerosis.2016.07.897", "27498397"]}, {"Citation": "Ferretti G., Bacchetti T., Sahebkar A. Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Prog. Lipid Res. 2015;60:50\u201373. doi: 10.1016/j.plipres.2015.08.003.", "ArticleIdList": ["10.1016/j.plipres.2015.08.003", "26416579"]}, {"Citation": "Shakour N., Ruscica M., Hadizadeh F., Cirtori C., Banach M., Jamialahmadi T., Sahebkar A. Statins and C-reactive protein: In silico evidence on direct interaction. Arch. Med. Sci. 2020;16:1432\u20131439. doi: 10.5114/aoms.2020.100304.", "ArticleIdList": ["10.5114/aoms.2020.100304", "PMC7667423", "33224343"]}, {"Citation": "Alikiaii B., Heidari Z., Bagherniya M., Askari G., Sathyapalan T., Sahebkar A. The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials. Mediat. Inflamm. 2021;2021:7104934. doi: 10.1155/2021/7104934.", "ArticleIdList": ["10.1155/2021/7104934", "PMC8418548", "34489618"]}, {"Citation": "Bahrami A., Parsamanesh N., Atkin S.L., Banach M., Sahebkar A. Effect of statins on toll-like receptors: A new insight to pleiotropic effects. Pharmacol. Res. 2018;135:230\u2013238. doi: 10.1016/j.phrs.2018.08.014.", "ArticleIdList": ["10.1016/j.phrs.2018.08.014", "30120976"]}, {"Citation": "Koushki K., Shahbaz S.K., Mashayekhi K., Sadeghi M., Zayeri Z.D., Taba M.Y., Banach M., Al-Rasadi K., Johnston T.P., Sahebkar A. Anti-inflammatory Action of Statins in Cardiovascular Disease: The Role of Inflammasome and Toll-Like Receptor Pathways. Clin. Rev. Allergy Immunol. 2021;60:175\u2013199. doi: 10.1007/s12016-020-08791-9.", "ArticleIdList": ["10.1007/s12016-020-08791-9", "PMC7985098", "32378144"]}, {"Citation": "Parsamanesh N., Moossavi M., Bahrami A., Fereidouni M., Barreto G., Sahebkar A. NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy. Int. Immunopharmacol. 2019;73:146\u2013155. doi: 10.1016/j.intimp.2019.05.006.", "ArticleIdList": ["10.1016/j.intimp.2019.05.006", "31100709"]}, {"Citation": "Pirro M., Simental-Mend\u00eda L.E., Bianconi V., Watts G.F., Banach M., Sahebkar A. Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies. J. Clin. Med. 2019;8:118. doi: 10.3390/jcm8010118.", "ArticleIdList": ["10.3390/jcm8010118", "PMC6352284", "30669380"]}, {"Citation": "Khalifeh M., Penson P.E., Banach M., Sahebkar A. Statins as anti-pyroptotic agents. Arch. Med. Sci. 2021;17:1414\u20131417. doi: 10.5114/aoms/141155.", "ArticleIdList": ["10.5114/aoms/141155", "PMC8425236", "34522271"]}, {"Citation": "Niedzielski M., Broncel M., Gorzelak-Pabi\u015b P., Wo\u017aniak E. New possible pharmacological targets for statins and ezetimibe. Biomed. Pharmacother. 2020;129:110388. doi: 10.1016/j.biopha.2020.110388.", "ArticleIdList": ["10.1016/j.biopha.2020.110388", "32559626"]}, {"Citation": "Zelenka J., Konco\u0161ov\u00e1 M., Ruml T. Targeting of stress response pathways in the prevention and treatment of cancer. Biotechnol. Adv. 2018;36:583\u2013602. doi: 10.1016/j.biotechadv.2018.01.007.", "ArticleIdList": ["10.1016/j.biotechadv.2018.01.007", "29339119"]}, {"Citation": "Boutant M., Cant\u00f3 C. SIRT1 metabolic actions: Integrating recent advances from mouse models. Mol. Metab. 2014;3:5\u201318. doi: 10.1016/j.molmet.2013.10.006.", "ArticleIdList": ["10.1016/j.molmet.2013.10.006", "PMC3929913", "24567900"]}, {"Citation": "Antonini-Canterin F., Di Nora C., Pellegrinet M., Vriz O., La Carrubba S., Carerj S., Zito C., Matescu A., Ravasel A., Cosei I., et al. Effect of uric acid serum levels on carotid arterial stiffness and intima-media thickness: A high resolution Echo-Tracking Study. Monaldi Arch. Chest Dis. 2019;89 doi: 10.4081/monaldi.2019.1007.", "ArticleIdList": ["10.4081/monaldi.2019.1007", "30968661"]}, {"Citation": "Antonini-Canterin F., Di Nora C., Poli S., Sparacino L., Iulian Cosei I., Ravasel A., Popescu A.C., Popescu B.A. Obesity, Cardiac Remodeling, and Metabolic Profile: Validation of a New Simple Index beyond Body Mass Index. J. Cardiovasc. Echogr. 2018;28:18\u201325. doi: 10.4103/jcecho.jcecho_63_17.", "ArticleIdList": ["10.4103/jcecho.jcecho_63_17", "PMC5875131", "29629255"]}, {"Citation": "Chen Y., Jiang Y., Yang Y., Huang X., Sun C. SIRT1 Protects Dopaminergic Neurons in Parkinson\u2019s Disease Models via PGC-1\u03b1-Mediated Mitochondrial Biogenesis. Neurotox. Res. 2021;39:1393\u20131404. doi: 10.1007/s12640-021-00392-4.", "ArticleIdList": ["10.1007/s12640-021-00392-4", "34251648"]}, {"Citation": "Di Nora C., Cioffi G., Iorio A., Rivetti L., Poli S., Zambon E., Barbati G., Sinagra G., Di Lenarda A. Systolic blood pressure target in systemic arterial hypertension: Is lower ever better? Results from a community-based Caucasian cohort. Eur. J. Intern. Med. 2018;48:57\u201363. doi: 10.1016/j.ejim.2017.08.029.", "ArticleIdList": ["10.1016/j.ejim.2017.08.029", "28893522"]}, {"Citation": "Mancia G., Fagard R., Narkiewicz K., Red\u00f3n J., Zanchetti A., B\u00f6hm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 2013;31:1281\u20131357. doi: 10.1097/01.hjh.0000431740.32696.cc.", "ArticleIdList": ["10.1097/01.hjh.0000431740.32696.cc", "23817082"]}, {"Citation": "Sun H., Gusdon A.M., Qu S. Effects of melatonin on cardiovascular diseases: Progress in the past year. Curr. Opin. Lipidol. 2016;27:408\u2013413. doi: 10.1097/MOL.0000000000000314.", "ArticleIdList": ["10.1097/MOL.0000000000000314", "PMC4947538", "27075419"]}, {"Citation": "Zhou R., Stouffer G.A., Smith S.C., Jr. Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes? J. Cardiovasc. Pharmacol. Ther. 2021;26:533\u2013549. doi: 10.1177/10742484211023632.", "ArticleIdList": ["10.1177/10742484211023632", "34138676"]}, {"Citation": "Chae C.W., Kwon Y.W. Cell signaling and biological pathway in cardiovascular diseases. Arch. Pharmacal. Res. 2019;42:195\u2013205. doi: 10.1007/s12272-019-01141-0.", "ArticleIdList": ["10.1007/s12272-019-01141-0", "30877558"]}, {"Citation": "Haigis M.C., Sinclair D.A. Mammalian sirtuins: Biological insights and disease relevance. Annu. Rev. Pathol. 2010;5:253\u2013295. doi: 10.1146/annurev.pathol.4.110807.092250.", "ArticleIdList": ["10.1146/annurev.pathol.4.110807.092250", "PMC2866163", "20078221"]}, {"Citation": "Houtkooper R.H., Cant\u00f3 C., Wanders R.J., Auwerx J. The secret life of NAD+: An old metabolite controlling new metabolic signaling pathways. Endocr. Rev. 2010;31:194\u2013223. doi: 10.1210/er.2009-0026.", "ArticleIdList": ["10.1210/er.2009-0026", "PMC2852209", "20007326"]}, {"Citation": "Bitterman K.J., Anderson R.M., Cohen H.Y., Latorre-Esteves M., Sinclair D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 2002;277:45099\u201345107. doi: 10.1074/jbc.M205670200.", "ArticleIdList": ["10.1074/jbc.M205670200", "12297502"]}, {"Citation": "Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M.W., Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429:771\u2013776. doi: 10.1038/nature02583.", "ArticleIdList": ["10.1038/nature02583", "PMC2820247", "15175761"]}, {"Citation": "Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell. 2004;116:551\u2013563. doi: 10.1016/S0092-8674(04)00126-6.", "ArticleIdList": ["10.1016/S0092-8674(04)00126-6", "14980222"]}, {"Citation": "Feige J.N., Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr. Opin. Cell Biol. 2008;20:303\u2013309. doi: 10.1016/j.ceb.2008.03.012.", "ArticleIdList": ["10.1016/j.ceb.2008.03.012", "PMC2447870", "18468877"]}, {"Citation": "Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403:795\u2013800. doi: 10.1038/35001622.", "ArticleIdList": ["10.1038/35001622", "10693811"]}, {"Citation": "Haigis M.C., Guarente L.P. Mammalian sirtuins\u2013emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006;20:2913\u20132921. doi: 10.1101/gad.1467506.", "ArticleIdList": ["10.1101/gad.1467506", "17079682"]}, {"Citation": "Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 2012;13:225\u2013238. doi: 10.1038/nrm3293.", "ArticleIdList": ["10.1038/nrm3293", "PMC4872805", "22395773"]}, {"Citation": "Westphal C.H., Dipp M.A., Guarente L. A therapeutic role for sirtuins in diseases of aging? Trends Biochem. Sci. 2007;32:555\u2013560. doi: 10.1016/j.tibs.2007.09.008.", "ArticleIdList": ["10.1016/j.tibs.2007.09.008", "17980602"]}, {"Citation": "Banks A.S., Kon N., Knight C., Matsumoto M., Guti\u00e9rrez-Ju\u00e1rez R., Rossetti L., Gu W., Accili D. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008;8:333\u2013341. doi: 10.1016/j.cmet.2008.08.014.", "ArticleIdList": ["10.1016/j.cmet.2008.08.014", "PMC3222897", "18840364"]}, {"Citation": "Yoshino J., Mills K.F., Yoon M.J., Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14:528\u2013536. doi: 10.1016/j.cmet.2011.08.014.", "ArticleIdList": ["10.1016/j.cmet.2011.08.014", "PMC3204926", "21982712"]}, {"Citation": "Moynihan K.A., Grimm A.A., Plueger M.M., Bernal-Mizrachi E., Ford E., Cras-M\u00e9neur C., Permutt M.A., Imai S. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005;2:105\u2013117. doi: 10.1016/j.cmet.2005.07.001.", "ArticleIdList": ["10.1016/j.cmet.2005.07.001", "16098828"]}, {"Citation": "Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., Falcone S., Valerio A., Cantoni O., Clementi E., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005;310:314\u2013317. doi: 10.1126/science.1117728.", "ArticleIdList": ["10.1126/science.1117728", "16224023"]}, {"Citation": "Hashimoto-Komatsu A., Hirase T., Asaka M., Node K. Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 2011;34:949\u2013956. doi: 10.1038/hr.2011.64.", "ArticleIdList": ["10.1038/hr.2011.64", "21677656"]}, {"Citation": "Sack M.N. The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. J. Mol. Cell. Cardiol. 2012;52:520\u2013525. doi: 10.1016/j.yjmcc.2011.11.004.", "ArticleIdList": ["10.1016/j.yjmcc.2011.11.004", "PMC3294048", "22119802"]}, {"Citation": "Yu S.S., Cai Y., Ye J.T., Pi R.B., Chen S.R., Liu P.Q., Shen X.Y., Ji Y. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-\u03baB-dependent transcriptional activity. Br. J. Pharmacol. 2013;168:117\u2013128. doi: 10.1111/j.1476-5381.2012.01903.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.01903.x", "PMC3570008", "22335191"]}, {"Citation": "Mich\u00e1n S., Li Y., Chou M.M., Parrella E., Ge H., Long J.M., Allard J.S., Lewis K., Miller M., Xu W., et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J. Neurosci. Off. J. Soc. Neurosci. 2010;30:9695\u20139707. doi: 10.1523/JNEUROSCI.0027-10.2010.", "ArticleIdList": ["10.1523/JNEUROSCI.0027-10.2010", "PMC2921958", "20660252"]}, {"Citation": "Min S.W., Cho S.H., Zhou Y., Schroeder S., Haroutunian V., Seeley W.W., Huang E.J., Shen Y., Masliah E., Mukherjee C., et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010;67:953\u2013966. doi: 10.1016/j.neuron.2010.08.044.", "ArticleIdList": ["10.1016/j.neuron.2010.08.044", "PMC3035103", "20869593"]}, {"Citation": "Jeong H., Cohen D.E., Cui L., Supinski A., Savas J.N., Mazzulli J.R., Yates J.R., 3rd, Bordone L., Guarente L., Krainc D. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 2011;18:159\u2013165. doi: 10.1038/nm.2559.", "ArticleIdList": ["10.1038/nm.2559", "PMC3509213", "22179316"]}, {"Citation": "Wu Y., Li X., Zhu J.X., Xie W., Le W., Fan Z., Jankovic J., Pan T. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson\u2019s disease. Neuro-Signals. 2011;19:163\u2013174. doi: 10.1159/000328516.", "ArticleIdList": ["10.1159/000328516", "PMC3699815", "21778691"]}, {"Citation": "Outeiro T.F., Kontopoulos E., Altmann S.M., Kufareva I., Strathearn K.E., Amore A.M., Volk C.B., Maxwell M.M., Rochet J.C., McLean P.J., et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science. 2007;317:516\u2013519. doi: 10.1126/science.1143780.", "ArticleIdList": ["10.1126/science.1143780", "17588900"]}, {"Citation": "Deng C.X. SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 2009;5:147\u2013152. doi: 10.7150/ijbs.5.147.", "ArticleIdList": ["10.7150/ijbs.5.147", "PMC2631220", "19173036"]}, {"Citation": "Alhazzazi T.Y., Kamarajan P., Verdin E., Kapila Y.L. SIRT3 and cancer: Tumor promoter or suppressor? Biochim. Biophys. Acta. 2011;1816:80\u201388. doi: 10.1016/j.bbcan.2011.04.004.", "ArticleIdList": ["10.1016/j.bbcan.2011.04.004", "PMC3129516", "21586315"]}, {"Citation": "Wang B., Ye Y., Yang X., Liu B., Wang Z., Chen S., Jiang K., Zhang W., Jiang H., Mustonen H., et al. SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases. EMBO Rep. 2020;21:e48183. doi: 10.15252/embr.201948183.", "ArticleIdList": ["10.15252/embr.201948183", "PMC7132198", "32141187"]}, {"Citation": "Hu A., Yang L.Y., Liang J., Lu D., Zhang J.L., Cao F.F., Fu J.Y., Dai W.J., Zhang J.F. SIRT2 modulates VEGFD-associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancer. Mol. Carcinog. 2020;59:1280\u20131291. doi: 10.1002/mc.23256.", "ArticleIdList": ["10.1002/mc.23256", "32965071"]}, {"Citation": "Hiratsuka M., Inoue T., Toda T., Kimura N., Shirayoshi Y., Kamitani H., Watanabe T., Ohama E., Tahimic C.G., Kurimasa A., et al. Proteomics-based identification of differentially expressed genes in human gliomas: Down-regulation of SIRT2 gene. Biochem. Biophys. Res. Commun. 2003;309:558\u2013566. doi: 10.1016/j.bbrc.2003.08.029.", "ArticleIdList": ["10.1016/j.bbrc.2003.08.029", "12963026"]}, {"Citation": "Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492\u2013496. doi: 10.1038/nature06736.", "ArticleIdList": ["10.1038/nature06736", "PMC2646112", "18337721"]}, {"Citation": "Schug T.T., Li X. Sirtuin 1 in lipid metabolism and obesity. Ann. Med. 2011;43:198\u2013211. doi: 10.3109/07853890.2010.547211.", "ArticleIdList": ["10.3109/07853890.2010.547211", "PMC3173813", "21345154"]}, {"Citation": "Horton J.D., Goldstein J.L., Brown M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Investig. 2002;109:1125\u20131131. doi: 10.1172/JCI0215593.", "ArticleIdList": ["10.1172/JCI0215593", "PMC150968", "11994399"]}, {"Citation": "Li X., Zhang S., Blander G., Tse J.G., Krieger M., Guarente L. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell. 2007;28:91\u2013106. doi: 10.1016/j.molcel.2007.07.032.", "ArticleIdList": ["10.1016/j.molcel.2007.07.032", "17936707"]}, {"Citation": "Heikkinen S., Auwerx J., Argmann C.A. PPARgamma in human and mouse physiology. Biochim. Biophys. Acta. 2007;1771:999\u20131013. doi: 10.1016/j.bbalip.2007.03.006.", "ArticleIdList": ["10.1016/j.bbalip.2007.03.006", "PMC2020525", "17475546"]}, {"Citation": "Kim H.S., Xiao C., Wang R.H., Lahusen T., Xu X., Vassilopoulos A., Vazquez-Ortiz G., Jeong W.I., Park O., Ki S.H., et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010;12:224\u2013236. doi: 10.1016/j.cmet.2010.06.009.", "ArticleIdList": ["10.1016/j.cmet.2010.06.009", "PMC2935915", "20816089"]}, {"Citation": "Wang F., Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1\u2032s repressive interaction with PPARgamma. Mol. Biol. Cell. 2009;20:801\u2013808. doi: 10.1091/mbc.e08-06-0647.", "ArticleIdList": ["10.1091/mbc.e08-06-0647", "PMC2633403", "19037106"]}, {"Citation": "Sahebkar A., Watts G.F. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect? Cardiovasc. Drugs Ther. 2013;27:559\u2013567. doi: 10.1007/s10557-013-6479-4.", "ArticleIdList": ["10.1007/s10557-013-6479-4", "23913122"]}, {"Citation": "Sahebkar A., Watts G.F. New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin. Ther. 2013;35:1082\u20131098. doi: 10.1016/j.clinthera.2013.06.019.", "ArticleIdList": ["10.1016/j.clinthera.2013.06.019", "23932550"]}, {"Citation": "Hegele R.A., Tsimikas S. Lipid-Lowering Agents. Circ. Res. 2019;124:386\u2013404. doi: 10.1161/CIRCRESAHA.118.313171.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.313171", "30702996"]}, {"Citation": "Sirtori C.R. The pharmacology of statins. Pharmacol. Res. 2014;88:3\u201311. doi: 10.1016/j.phrs.2014.03.002.", "ArticleIdList": ["10.1016/j.phrs.2014.03.002", "24657242"]}, {"Citation": "Melexopoulou C., Marinaki S., Oikonomou E., Bonios M.J., Theofilis P., Miliou A., Siasos G., Tousoulis D., Boletis J.N. PCSK9 and inflammatory biomarkers in the early post kidney transplantation period. Eur. Rev. Med. Pharmacol. Sci. 2021;25:4762\u20134772. doi: 10.26355/eurrev_202107_26388.", "ArticleIdList": ["10.26355/eurrev_202107_26388", "34337724"]}, {"Citation": "Turner T.A., Stein E.A. Targeting PCSK9 inhibitors to those who will benefit most. Lancet Diabetes Endocrinol. 2022;10:301\u2013303. doi: 10.1016/S2213-8587(22)00086-9.", "ArticleIdList": ["10.1016/S2213-8587(22)00086-9", "35378071"]}, {"Citation": "Sosnowska B., Mazidi M., Penson P., Gluba-Brz\u00f3zka A., Rysz J., Banach M. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis. Atherosclerosis. 2017;265:275\u2013282. doi: 10.1016/j.atherosclerosis.2017.08.027.", "ArticleIdList": ["10.1016/j.atherosclerosis.2017.08.027", "28870631"]}, {"Citation": "Tummala R., Gupta M., Devanabanda A.R., Bandyopadhyay D., Aronow W.A., Ray K.K., Mamas M., Ghosh R.K. Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis. Ann. Med. 2022;54:1287\u20131296. doi: 10.1080/07853890.2022.2059559.", "ArticleIdList": ["10.1080/07853890.2022.2059559", "PMC9090378", "35533049"]}, {"Citation": "Hong W., Wei Z., Qiu Z., Li Z., Fu C., Ye Z., Xu X. Atorvastatin promotes bone formation in aged apoE(\u2212/\u2212) mice through the Sirt1-Runx2 axis. J. Orthop. Surg. Res. 2020;15:303. doi: 10.1186/s13018-020-01841-0.", "ArticleIdList": ["10.1186/s13018-020-01841-0", "PMC7412819", "32762716"]}, {"Citation": "Ishibashi Y., Nakashima S., Matsui T., Yamagishi S. Rosuvastatin restores advanced glycation end product-induced decrease in sirtuin 1 (SIRT1) mRNA levels in THP-1 monocytic cells through its anti-oxidative properties. Int. J. Cardiol. 2013;169:e102\u2013e103. doi: 10.1016/j.ijcard.2013.10.034.", "ArticleIdList": ["10.1016/j.ijcard.2013.10.034", "24383118"]}, {"Citation": "Dymkowska D., Wrzosek A., Zab\u0142ocki K. Atorvastatin and pravastatin stimulate nitric oxide and reactive oxygen species generation, affect mitochondrial network architecture and elevate nicotinamide N-methyltransferase level in endothelial cells. J. Appl. Toxicol. 2021;41:1076\u20131088. doi: 10.1002/jat.4094.", "ArticleIdList": ["10.1002/jat.4094", "33073877"]}, {"Citation": "Ota H., Eto M., Kano M.R., Kahyo T., Setou M., Ogawa S., Iijima K., Akishita M., Ouchi Y. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler. Thromb. Vasc. Biol. 2010;30:2205\u20132211. doi: 10.1161/ATVBAHA.110.210500.", "ArticleIdList": ["10.1161/ATVBAHA.110.210500", "20705918"]}, {"Citation": "Tabuchi T., Satoh M., Itoh T., Nakamura M. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: Effect of statins on SIRT1 and microRNA-34a expression. Clin. Sci. 2012;123:161\u2013171. doi: 10.1042/CS20110563.", "ArticleIdList": ["10.1042/CS20110563", "22364258"]}, {"Citation": "\u00c7elik H., Karahan H., Kelicen-U\u011fur P. Effect of atorvastatin on A\u03b2(1-42) -induced alteration of SESN2, SIRT1, LC3II and TPP1 protein expressions in neuronal cell cultures. J. Pharm. Pharmacol. 2020;72:424\u2013436. doi: 10.1111/jphp.13208.", "ArticleIdList": ["10.1111/jphp.13208", "31846093"]}, {"Citation": "Lin M.C., Hsing C.H., Li F.A., Wu C.H., Fu Y.S., Cheng J.K., Huang B. Rosuvastatin Modulates the Post-Translational Acetylome in Endothelial Cells. Acta Cardiol. Sin. 2014;30:67\u201373.", "ArticleIdList": ["PMC4804823", "27122770"]}, {"Citation": "Kok S.H., Lin L.D., Hou K.L., Hong C.Y., Chang C.C., Hsiao M., Wang J.H., Lai E.H., Lin S.K. Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling. Arthritis Rheum. 2013;65:639\u2013649. doi: 10.1002/art.37807.", "ArticleIdList": ["10.1002/art.37807", "23239110"]}, {"Citation": "Du G., Song Y., Zhang T., Ma L., Bian N., Chen X., Feng J., Chang Q., Li Z. Simvastatin attenuates TNF-\u03b1-induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1. Int. J. Mol. Med. 2014;34:177\u2013182. doi: 10.3892/ijmm.2014.1740.", "ArticleIdList": ["10.3892/ijmm.2014.1740", "24718722"]}, {"Citation": "Liu H., Yang J., Wang K., Niu T., Huang D. Moderate- and Low-Dose of Atorvastatin Alleviate Cognition Impairment Induced by High-Fat Diet via Sirt1 Activation. Neurochem. Res. 2019;44:1065\u20131078. doi: 10.1007/s11064-019-02738-z.", "ArticleIdList": ["10.1007/s11064-019-02738-z", "30820818"]}, {"Citation": "Yang H., Huang F., Tao Y., Zhao X., Liao L., Tao X. Simvastatin ameliorates ionizing radiation-induced apoptosis in the thymus by activating the AKT/sirtuin 1 pathway in mice. Int. J. Mol. Med. 2017;40:762\u2013770. doi: 10.3892/ijmm.2017.3047.", "ArticleIdList": ["10.3892/ijmm.2017.3047", "PMC5547942", "28677744"]}, {"Citation": "de las Heras N., Valero-Mu\u00f1oz M., Ballesteros S., G\u00f3mez-Hern\u00e1ndez A., Mart\u00edn-Fern\u00e1ndez B., Blanco-Rivero J., Cachofeiro V., Benito M., Balfag\u00f3n G., Lahera V. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet. Nutr. Metab. Cardiovasc. Dis. 2013;23:1107\u20131114. doi: 10.1016/j.numecd.2012.11.009.", "ArticleIdList": ["10.1016/j.numecd.2012.11.009", "23434394"]}, {"Citation": "Gong X., Ma Y., Ruan Y., Fu G., Wu S. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta. Exp. Gerontol. 2014;52:9\u201317. doi: 10.1016/j.exger.2014.01.015.", "ArticleIdList": ["10.1016/j.exger.2014.01.015", "24463049"]}, {"Citation": "Wu Z.Y., Li H., Tang Y.J. Effect of simvastatin on the SIRT2/NF-\u03baB pathway in rats with acute pulmonary embolism. Pharm. Biol. 2018;56:511\u2013518. doi: 10.1080/13880209.2018.1508239.", "ArticleIdList": ["10.1080/13880209.2018.1508239", "PMC6282435", "31070532"]}, {"Citation": "Shi M.Y., Bang I.H., Han C.Y., Lee D.H., Park B.H., Bae E.J. Statin suppresses sirtuin 6 through miR-495, increasing FoxO1-dependent hepatic gluconeogenesis. Theranostics. 2020;10:11416\u201311427. doi: 10.7150/thno.49770.", "ArticleIdList": ["10.7150/thno.49770", "PMC7545997", "33052223"]}, {"Citation": "Yama\u00e7 A.H., K\u0131l\u0131\u00e7 \u00dc. Effect of statins on sirtuin 1 and endothelial nitric oxide synthase expression in young patients with a history of premature myocardial infarction. Turk Kardiyoloji Dernegi Arsivi Turk Kardiyoloji Derneginin Yayin Organidir. 2018;46:205\u2013215. doi: 10.5543/tkda.2018.32724.", "ArticleIdList": ["10.5543/tkda.2018.32724", "29664427"]}, {"Citation": "Kim J.H., Lee J.M., Kim J.H., Kim K.R. Fluvastatin activates sirtuin 6 to regulate sterol regulatory element-binding proteins and AMP-activated protein kinase in HepG2 cells. Biochem. Biophys. Res. Commun. 2018;503:1415\u20131421. doi: 10.1016/j.bbrc.2018.07.057.", "ArticleIdList": ["10.1016/j.bbrc.2018.07.057", "30078674"]}, {"Citation": "Lei J., Gu X., Ye Z., Shi J., Zheng X. Antiaging effects of simvastatin on vascular endothelial cells. Clin. Appl. Thromb./Hemost. 2014;20:212\u2013218. doi: 10.1177/1076029612458967.", "ArticleIdList": ["10.1177/1076029612458967", "22964779"]}, {"Citation": "Zullo A., Guida R., Sciarrillo R., Mancini F.P. Redox Homeostasis in Cardiovascular Disease: The Role of Mitochondrial Sirtuins. Front. Endocrinol. (Lausanne) 2022;13:858330. doi: 10.3389/fendo.2022.858330.", "ArticleIdList": ["10.3389/fendo.2022.858330", "PMC8971707", "35370975"]}, {"Citation": "Wang C.H., Wei Y.H. Roles of Mitochondrial Sirtuins in Mitochondrial Function, Redox Homeostasis, Insulin Resistance and Type 2 Diabetes. Int. J. Mol. Sci. 2020;21:5266. doi: 10.3390/ijms21155266.", "ArticleIdList": ["10.3390/ijms21155266", "PMC7432223", "32722262"]}, {"Citation": "Luo Y.X., Tang X., An X.Z., Xie X.M., Chen X.F., Zhao X., Hao D.L., Chen H.Z., Liu D.P. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. Eur. Heart J. 2017;38:1389\u20131398. doi: 10.1093/eurheartj/ehw138.", "ArticleIdList": ["10.1093/eurheartj/ehw138", "27099261"]}, {"Citation": "Lynn E.G., McLeod C.J., Gordon J.P., Bao J., Sack M.N. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett. 2008;582:2857\u20132862. doi: 10.1016/j.febslet.2008.07.016.", "ArticleIdList": ["10.1016/j.febslet.2008.07.016", "PMC2566947", "18640115"]}, {"Citation": "Alcendor R.R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., Tian B., Wagner T., Vatner S.F., Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007;100:1512\u20131521. doi: 10.1161/01.RES.0000267723.65696.4a.", "ArticleIdList": ["10.1161/01.RES.0000267723.65696.4a", "17446436"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "7"}, {"Year": "2022", "Month": "5", "Day": "17"}, {"Year": "2022", "Month": "5", "Day": "18"}, {"Year": "2022", "Month": "5", "Day": "28", "Hour": "1", "Minute": "27"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35629426", "PMC9146832", "10.3390/life12050760", "life12050760"]}}], "PubmedBookArticle": []}